Alleghany Corp (Y)

$847.79 0.00 (0.00%)

19:00 EDT Y Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 11.41B

PE Ratio 33.40

EPS 25.38

Volume (Avg. Vol.)

Day's Range -

52-Week Range -

Dividend & Yield N/A (N/A)

Y Stock Predictions, Articles, and Alleghany Corp News

From the Web

JMP Securities Sticks to Their Hold Rating for Alleghany (Y)

From TipRanks Jul 27, 2022

In a report issued on July 18, Matt...

Looking Into Alleghany's Return On Capital Employed

From Benzinga May 26, 2022

Pulled from Benzinga Pro data, Alleghany (NYSE:Y) posted Q1 earnings of $168.89 million, an increase from Q4 of 69.66%. Sales dropped to $1.60 billion, a 13.99% decrease between quarters.

Analysis: Should You Be Afraid Of A Monkeypox Pandemic?

From Benzinga May 20, 2022

The coronavirus pandemic has yet to be firmly tucked into the history books even as a new health threat emerges: monkeypox, a rare infectious virus that has suddenly become more prevalent in Europe and is now being detected in North America. Should people be concerned that a new health crisis is suddenly percolating? The answer, it seems, is both yes and no.

Alleghany: Q1 Earnings Insights

From Benzinga May 11, 2022

Alleghany (NYSE:Y) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:20 PM. Here's what investors need to know about the announcement. Earnings Alleghany beat estimated earnings by 20.83%, reporting an EPS of $18.85 versus an estimate of $15.6.

Recap: Alleghany Q1 Earnings

From Benzinga May 5, 2022

Alleghany (NYSE:Y) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:20 PM. Here's what investors need to know about the announcement. Earnings Alleghany beat estimated earnings by 20.83%, reporting an EPS of $18.85 versus an estimate of $15.6.

Earnings Scheduled For May 5, 2022

From Benzinga May 5, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

ADVERTISEMENT